ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,414Medicare Part D Prescriptions Filled, Including Refills

Rank: 104 out of 680

$1.11M Total Retail Price of All Prescriptions

Rank: 63 out of 680

360 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 360 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

16% of this provider’s 360 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 13,508 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
OMEPRAZOLE 367 329 1 7
LEVOTHYROXINE SODIUM 340 311 2 2
AMLODIPINE BESYLATE 331 309 3 1
FUROSEMIDE 315 301 4 6
POTASSIUM CHLORIDE 315 267 4 14
LISINOPRIL 312 245 6 5
DONEPEZIL HCL 308 287 7 27
GABAPENTIN 265 202 8 15
LANTUS 265 186 8 49
NAMENDA 262 262 10 35
HYDROCODONE-ACETAMINOPHEN 252 209 S3 11 4
HYDROCHLOROTHIAZIDE 217 202 12 9
SIMVASTATIN 205 190 13 3
CYMBALTA 203 162 14 46
CARBIDOPA-LEVODOPA 200 188 15 117
METOLAZONE 199 195 16 201
POLYETHYLENE GLYCOL 3350 191 169 17 62
NOVOLIN R 190 168 18 113
ZOLPIDEM TARTRATE 184 181 19 17
METOPROLOL TARTRATE 173 160 20 12
ATORVASTATIN CALCIUM 168 136 21 11
ESCITALOPRAM OXALATE 166 134 22 45
RISPERIDONE 158 158 23 80
RANITIDINE HCL 157 124 24 56
TRAMADOL HCL 156 118 25 18
ADVAIR DISKUS 155 154 26 53
CARVEDILOL 155 151 26 23
GLIPIZIDE 152 130 28 63
CITALOPRAM HBR 143 129 29 22
TRAZODONE HCL 141 103 30 48
NORTRIPTYLINE HCL 137 124 31 283
CLONIDINE HCL 136 106 32 36
QUETIAPINE FUMARATE 135 135 33 64
ALENDRONATE SODIUM 134 128 34 32
SPIRIVA 134 134 34 70
LEVETIRACETAM 128 71 36 120
CLOPIDOGREL 123 118 37 26
OLANZAPINE 120 107 38 116
SERTRALINE HCL 118 106 39 28
METOPROLOL SUCCINATE 110 101 40 13
NOVOLOG 105 62 41 167
NEXIUM 101 83 42 16
DIGOXIN 91 91 43 58
DOXYCYCLINE HYCLATE 91 88 43 95
MIRTAZAPINE 89 72 45 78
GLIPIZIDE ER 88 79 46 108
PLAVIX 88 83 46 39
KLOR-CON M20 85 74 48 61
TRAVATAN Z 83 80 49 266
ABILIFY 77 41 50 178
IPRATROPIUM-ALBUTEROL 75 73 51 207
MEGESTROL ACETATE 74 67 R 52 88
ALBUTEROL SULFATE 73 72 53 154
SPIRONOLACTONE 70 70 54 82
METFORMIN HCL 70 52 54 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 70 54 37
IPRATROPIUM BROMIDE 70 70 54 211
DIVALPROEX SODIUM 69 23 58 110
OXYBUTYNIN CHLORIDE ER 69 63 58 143
BENZTROPINE MESYLATE 67 56 R 60 137
FLUOXETINE HCL 66 66 61 74
PREDNISONE 64 64 62 50
FORTICAL 63 52 63 353
ATENOLOL 61 56 64 19
BUSPIRONE HCL 61 61 64 144
NAPROXEN 60 47 66 121
AMANTADINE 60 47 66 387
ALLOPURINOL 59 59 68 33
CYCLOBENZAPRINE HCL 59 28 R 68 81
ENOXAPARIN SODIUM 59 58 68 260
AMITRIPTYLINE HCL 58 31 R 71 47
CRESTOR 58 58 71 25
DORZOLAMIDE-TIMOLOL 57 49 73 299
BETHANECHOL CHLORIDE 56 56 74 294
MELOXICAM 56 43 74 24
MUPIROCIN 56 53 74 130
RAMIPRIL 55 55 77 69
SYNTHROID 55 55 77 38
TAMSULOSIN HCL 54 54 79 34
FINASTERIDE 54 54 79 109
PANTOPRAZOLE SODIUM 52 50 81 30
ISOSORBIDE MONONITRATE ER 51 51 82 59
FLUTICASONE PROPIONATE 51 48 82 41
AZITHROMYCIN 50 43 84 42
JANUVIA 50 38 84 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 12, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.